Keyphrases
Cuban
100%
Cost-plus
100%
Drug Companies
100%
Medicare
91%
Clinical Trials
42%
Medicare Part D
38%
Drug Development
29%
Cost-savings Potential
25%
Affordable Solution
25%
Trametinib
25%
Dabrafenib
25%
Risk Outcomes
25%
Patient Outcomes
25%
Risk-benefit
25%
Patient Benefit
25%
Anxiety Disorders
25%
Core Outcome Set
25%
Orthopedics
25%
Diabetes Medications
25%
Trialists
25%
Web-based Survey
25%
Seizure
25%
Medicaid
25%
Patient Risk
25%
Potential Savings
24%
Accelerated Approval
16%
Cost Savings
15%
Spending Data
11%
Cost Difference
10%
Sectional Analysis
10%
Potential Cost Savings
9%
Unit Price
8%
BRAFV600
8%
Drug Costs
8%
Health Care Costs
8%
Malignancy
8%
Financial Burden
7%
Cumulative Costs
7%
Medicare Spending
7%
Company Website
6%
Data Extraction
6%
Healthcare Expenditure
6%
Prescription Drugs
6%
Cost Reduction
6%
Dispensing Fees
6%
Metformin
5%
Medication Cost
5%
Cross-sectional Review
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cross Sectional Study
53%
Drug Development
50%
Clinical Trial
46%
Prescription Drug
37%
Chronicity
25%
Trametinib
25%
Dabrafenib
25%
Myositis
25%
Muscle Relaxant Agent
25%
Myalgia
25%
Anxiety Disorder
25%
Fluticasone Propionate
25%
Drug Analysis
25%
Metformin
25%
Tablet
25%
Atopic Dermatitis
25%
Anticonvulsive Agent
25%
Disease
25%
Diabetes Mellitus
25%
Gout
25%
Drug Screening
16%
Generic Drug
12%
Prevalence
12%